Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Frontotemporal Dementia
NCT03260920Phase 2Unknown
- Start
- Jan 2018
- Primary completion
- Jun 2023
- Countries
- 2
01
Overview
A Phase 2 trial of oxytocin nasal spray in frontotemporal dementia (FTD). Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT03260920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260920.